ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

17 Jul 2026

ECO Animal Health: FY Results Investor Presentation video - 16 July 2026

David Hallas (CEO) and Chris Wilks (CFO) of ECO Animal Health conducted a live presentation covering the company's Full-Year Interim Results for the period to 31 March. Highlights included a 10% increase in Group Revenue, and Gross Margins rising to 48.6% (FY 2025: 45.1%), driven by growth in higher-margin markets.

The team discussed the launch of ECOVAXXIN MS in Europe, the cautious outlook for China and the R&D growth pipeline. They also provided a detailed financial and operational review and the outlook for ECO, while answering a range of questions submitted by viewers.

The full video has been divided into chapters, for ease of viewing, as below:
00:00 Introduction and Overview
09:05 Financial Review
24:10 R&D Growth Engine
31:11 Summary & Outlook
32:44 Q&A

Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 3rd Floor, 80 Cheapside, London, EC2V 6EE

Website design & development by Breckenridge